, Tracking Stock Market Picks
Enter Symbol:
Rating: NBRV
Buy $15

Nabriva Therapeutics (NBRV) rated to Buy with price target $15 by Needham

Monday,  Oct 12, 2015  8:25 AM ET by Betsy O'Brien Harrison

Needham rated Nabriva
Therapeutics (NBRV) to Buy with price target $15.

Needham & Company, LLC focuses on emerging growth companies in technology, biotechnology and life sciences. The firm's research goal is to service the needs of growth-oriented institutional clients. Needham & Company has established itself as a premier specialty investment bank providing timely and valuable analysis on companies that are under-covered by the majority of Wall Street firms.

RSS Feed | |  Facebook |  Twitter |  Google Plus
Home | Terms of Use | Advertise | FAQ | Support Page | Contact Us | About Us | Privacy Policy